ArticleTranslational andrology and urology2025
Association between delayed graft function and cytomegalovirus infection after renal transplant.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Delayed graft function (DGF) is a significant risk factor for renal allograft failure. This study aimed to estimate the incidence of cytomegalovirus (CMV) infection and investigate whether DGF is associated with an increased risk of CMV infection in renal transplant recipients. Methods: In this single-center, retrospective cohort study, we analyzed CMV outcomes in deceased donor renal transplant recipients with and without DGF. Univariate and multivariate odds ratio were calculated using a Cox proportional hazards model. Results: Data from 124 recipients (mean age: 44.72±9.97 years; 89 males) were evaluated. Cytomegaloviruria was diagnosed in 16 patients (12.9%) within one year post-transplantation. Patients with DGF exhibited a significantly higher risk of cytomegaloviruria compared to those without DGF (P=0.02). Additionally, the DGF group demonstrated lower lymphocyte proportions and absolute CD4 Conclusions: Our findings suggest that renal transplant recipients with DGF are at an increased risk of developing cytomegaloviruria. These results highlight the need for prospective studies to evaluate the utility of monitoring CMV viral loads and CD4
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.